What is BPC-157 and what is the evidence base?
BPC-157 is a synthetic peptide derived from a gastric protein, studied primarily for tissue-repair and gastrointestinal applications. The current evidence base is predominantly preclinical (animal models) with limited human clinical trials. Provider-reviewed use is candidacy- and context-specific, never universal.
Full answer
BPC-157 is a synthetic 15-amino-acid peptide derived from a gastric protein and studied preclinically for tissue repair, tendon and ligament healing, and gastrointestinal mucosal protection. The current evidence base is predominantly animal-model and mechanistic, with limited high-quality human clinical trial data. This is the honest framing oMeds uses with members: the preclinical signal is interesting, the human evidence base is still maturing, and any use is candidacy- and context-specific rather than universal. Provider review is required before initiation and continues throughout. We do not recommend self-sourcing peptides from non-pharmacy supply chains; identity, purity, and dosing accuracy are not verifiable outside the regulated pathway.
Educational. Not a substitute for individualized provider review.
- Peptide intelligence — Primary source · oMeds
- Reviewed by Dr. Laura Purdy, MD, MBA · Clinical Director, oMeds · Last reviewed 2026-05-29